Sign In
Book a Demo

Entering GSK, Alphalife Sciences Supports Pharmaceutical Companies in Embracing AI.

In the surge of generativeAI, global pharmaceutical companies are actively exploring how to leverage AI to accelerate medical innovation and clinical trial processes. In this CMAC Clinical Research Informatization Club event at GSK industry colleagues will delve into 'The Latest Developments in Large Language Models in China' and 'Exploration of AI Applications in Pharmaceutical and Vaccine Development in China'.Ms. Sharon Chen, CEO of Alphalife Sciences and Chairperson of the CMAC Clinical Research Informatization Club, is invited as an honorary guest to share her profound insights on how generativeAI can assist enterprises in transforming clinical informatization. Additionally, Bogong Zhu, Chief Product Officer of Alphalife Sciences and a seasoned AI product expert, is also invited to participate in this event on AI and Pharmaceutical Innovation. Let's explore the endless possibilities of AI together and move towards a smarter and more efficient new era of clinical research!

Nov 23, 2023 Read More

AlphaLife Sciences Invited to Attend the AI in Pharma Annual Conference | October 4-5 in Boston

The 2023 AI in Pharma Annual Conference will be held from Wednesday, October 4th, to Thursday, October 5th, 2023, in Boston. AI in Pharma is dedicated to providing a global platform for the exchange of ideas and collaboration to drive innovation in science and medicine. This two-day conference will explore specific applications and key challenges of artificial intelligence in drug discovery and clinical trials.

Sep 27, 2023 Read More

AlphaLife Sciences Invited to Attend SAPA Annual Meeting | September 29-30 in New Jersey

The 2023 SAPA Annual Meeting and 30th Anniversary Celebration will take place from September 29th (Friday) to 30th (Saturday) at the Hyatt Regency New Brunswick hotel in New Jersey. AlphaPrime Life Sciences is honored to sponsor this annual event. The theme of this year's meeting is "TOWARDS A SHARED VISION: ADVANCING PHARMACEUTICALS THROUGH COLLABORATION AND INNOVATION."

Sep 27, 2023 Read More

How AlphaLife uses AI automation to modernize the life sciences industry

The power of AI to process and analyze vast amounts of data at unprecedented speeds holds immense potential for revolutionizing scientific research. AI algorithms can identify patterns, correlations, and anomalies in complex datasets, leading to new discoveries and insights. AlphaPrime has positioned itself as a forerunner of this new frontier, developing SaaS products for the life sciences and healthcare industries. Their core product platform, AlphaPrime, offers a suite of products for protocol design and trials data collection using cloud computing, AI, and big data. AlphaPrime’s AI automation offerings are fully configurable to meet the needs of clinical trials and other health needs.

Jul 18, 2023 Read More

Connecting with OpenAI, AlphaLife Sciences Opens ChatGPT Function for Digitalization in Clinical Trials

May 9, 2023 — Singapore-based AlphaPrime Life Sciences (referred to as "AlphaPrime") announced the official integration of their clinical research cloud platform, AuroraPrime, with OpenAI's technology. This integration has enabled the practical application of ChatGPT in the digitalization and intelligence of clinical research. AlphaPrime has already begun exploring and expanding the application scenarios with several well-known innovative drug development companies. Additionally, AlphaPrime actively tests and fine-tunes the performance and effectiveness of various renowned AGI models in similar contexts, accelerating the exploration of large language models like ChatGPT in the field of clinical research.

May 09, 2023 Read More

AlphaLife: Using AI to turbocharge clinical trial processes

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s life science arm) and the Engineering Site Lead of Google Shanghai. Sharon is an IT veteran with 20+ years of rich experience in the industry, 15 of which were gained at Google. Sharon earned her bachelor’s degree in automation from Shanghai Jiaotong University, and her master’s degree in computer science from Texas A&M University.

Apr 14, 2023 Read More

AlphaLife Sciences Collaborates with CSPC to Explore Enterprise-level Intelligent Medical Writing System

On March 30, 2023 — AlphaPrime Life Sciences Group (hereinafter referred to as "AlphaPrime"), announced its collaboration with CSPC Pharmaceutical Group Co., Ltd (referred to as "CSPC"), one of China's leading innovative pharmaceutical companies, to officially launch the AuroraPrime Create (referred to as "Prime Create"), an intelligent clinical research document generation system. CSPC will fully utilize the system to write clinical research protocols and CSR (clinical study reports) to improve content writing, cross-team collaboration, and approval process efficiency, achieve digitization and structuring of document content, establish an enterprise-level content knowledge base, and realize comprehensive knowledge accumulation and application for innovative research and development.

Mar 30, 2023 Read More

AlphaLife CEO, Ms. Xiao Chen, Selected as One of Forbes China's Top 20 Promising Businesswomen in 2023

AlphaPrime Life Sciences, a company focused on the intelligent clinical research platform in the life sciences field, announced that its CEO, Ms. Xiao Chen (Sharon Chen), has been selected as one of Forbes China's Top 20 Promising Businesswomen for 2023. The list recognizes women who have made significant contributions to their respective industries and have demonstrated strong growth potential.AlphaPrime Life Science, a company focused on the intelligent clinical research platform in the life sciences field, announced that its CEO, Ms. Xiao Chen (Sharon Chen), has been selected as one of Forbes China's Top 20 Promising Businesswomen for 2023. The list recognizes women who have made significant contributions to their respective industries and have demonstrated strong growth potential.

Mar 10, 2023 Read More

AlphaLife Sciences Completes Tens of Millions of Dollars in A+ Round Financing, Empowering Digitalization of Life Science Clinical Research

October 12, 2022 — AlphaPrime Life Sciences, a new-generation leader in digitalizing life science clinical research, has recently completed tens of millions of dollars in A+ round financing. The round was led by Han Kang Capital with participation from B Capital, and exclusive financial advisory from Huaxing Capital.October 12, 2022 — AlphaPrime Life Sciences, a new-generation leader in digitalizing life science clinical research, has recently completed tens of millions of dollars in A+ round financing. The round was led by Han Kang Capital with participation from B Capital, and exclusive financial advisory from Huaxing Capital.

Oct 12, 2022 Read More

Product Launch: With Intelligent Content Recommendations, Prime Create 2.0 Clinical Research Document Generation System Is Online

On August 17, 2022 - AlphaPrime Life Sciences Group (hereinafter referred to as "AlphaPrime") confirmed that the independent and innovative clinical research document generation system, AuroraPrime Create (referred to as "Prime Create"), will undergo important updates with the release of version 2.0. As a unique professional writing system for the life science industry's information technology field, Prime Create 2.0 provides leading features such as intelligent content recommendations, a rich template library, and full-process collaborative management, ushering in a new era for clinical research document writing such as the trial protocol.

Aug 17, 2022 Read More

Learn more about
AuroraPrime's leading solutions

Contact Us